Cite
Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
MLA
Sumiyoshi, Yoshiteru, et al. “Oral Estramustine Phosphate and Oral Etoposide for the Treatment of Hormone-Refractory Prostate Cancer.” International Journal of Urology, vol. 7, no. 7, July 2000, pp. 243–47. EBSCOhost, https://doi.org/10.1046/j.1442-2042.2000.00183.x.
APA
Sumiyoshi, Y., Hashine, K., Nakatsuzi, H., Yamashita, Y., & Karashima, T. (2000). Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer. International Journal of Urology, 7(7), 243–247. https://doi.org/10.1046/j.1442-2042.2000.00183.x
Chicago
Sumiyoshi, Yoshiteru, Katsuyoshi Hashine, Hironori Nakatsuzi, Yokihiko Yamashita, and Takashi Karashima. 2000. “Oral Estramustine Phosphate and Oral Etoposide for the Treatment of Hormone-Refractory Prostate Cancer.” International Journal of Urology 7 (7): 243–47. doi:10.1046/j.1442-2042.2000.00183.x.